Menu
Overview
[JAPANESE LANGUAGE ONLY]
Program Committee
-
Ryuta Asada, PhD • Associate Professor, Deputy Chief of the Center
Gifu University Hospital, Japan -
Noriko Fujiwara, MS, RN • Research Nurse, Project Researcher, Department of Palliative Medicine
IMSUT Hospital, The Institute of Medical Science, The University of Tokyo, Japan -
Koji Iwasaki, PhD • Professor, Academic Clinical Research Center,
Osaka University Hospital, Japan -
Kayoko Kikuchi, PhD • Chief, Division of Management and Strategy
National Center For Child Health and Development, Japan -
Hisashi Koike, PhD • Review Director, Office of New Drug IV
Pharmaceuticals and Medical Devices Agency (PMDA), Japan -
Koichi Konno, PMP • Chief Executive
PM Consulting Positive Intention, Japan -
Noriatsu Kono, MPharm • Managing Director, Department of Innovative Drug Discovery and Development
Japan Agency for Medical Research and Development (AMED), Japan -
Kotone Matsuyama, RPh • Professor, Department of Health Policy and Management
Nippon Medical School, Japan -
Tomoko Okudaira • Deputy Review Director, Office of New Drug II
Pharmaceuticals and Medical Devices Agency (PMDA), Japan -
Michiyo Oshima, MBA • Senior Director, Japan Portfolio & Project Management Development Japan
Pfizer R&D Japan, Japan -
Takashi Sato, MSc, PMP • Manager, Resource Management Group, R&D Planning Department
Kyowa Kirin Co., Ltd., Japan -
Shinobu Shimizu, PhD • Associate Professor, Department of Advanced Medicine
Nagoya Univeresity Hospital, Japan -
Shuji Sumida, MSc, RPh • Senior Specialist, Business Strategy & Compliance Department
Chugai Pharmaceutical Co., Ltd., Japan -
Atsushi Tsukamoto, PhD, MSc • Vice President, New Drug Regulatory Affairs
Daiichi Sankyo Co., Ltd., Japan
